Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Title
Intervention Indication Therapeutic Area Year Actions
Mobocertinib for locally advanced or metastatic NSCLC TAK-788 (AP32788; Mobocertinib) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Mirikizumab for the treatment of moderately to severely active ulcerative colitis Mirikizumab (LY3074828) Ulcerative colitis Gastroenterology 2021 View  |  Download
Mavorixafor for WHIM syndrome Mavorixafor (X4P-001) WHIM syndrome Genetic Disorders , Immunology 2021 View  |  Download
Mavacamten for hypertrophic cardiomyopathy Mavacamten (MYK-461) Hypertrophic cardiomyopathy (HCM) Cardiovascular System 2021 View  |  Download
Maralixibat for cholestatic liver disease in patients with Alagille syndrome Maralixibat chloride (SHP625) Alagille syndrome Genetic Disorders 2021 View  |  Download
Magrolimab in addition to azacitidine for myelodysplastic syndromes - First-line Azacitidine (Vidaza; CC-486) , Magrolimab (Hu5F9-G4) Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2021 View  |  Download
Loncastuximab Tesirine for relapsed or refractory diffuse large B-cell lymphoma – third line Loncastuximab Tesirine (ADCT-402; Lonca; Zylonta) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2021 View  |  Download
Liposomal bupivacaine for post-operative pain in children Liposomal bupivacaine (Exparel) Post-operative pain Pain Relief 2021 View  |  Download
Ligelizumab for chronic spontaneous urticaria Ligelizumab (QGE 031) Chronic spontaneous urticaria (CSU) Dermatology 2021 View  |  Download
Levodopa, carbidopa monohydrate and entacapone intestinal gel for severe motor fluctuations in advanced Parkinson’s Disease Carbidopa (carbidopa monohydrate) , Entacapone (Comtess; OR-611) , Levodopa (ND0612; Inbrija; CVT-30) Parkinson's disease Neurology 2021 View  |  Download
1 2 6 7 8 9 10 14 15
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications